OSSTEC raises €2.9M Series A round
8 April 2025· London, United Kingdom· health, orthopaedics, materials, biotech, b2b, deep_hardware
The funding will be used to obtain regulatory approval in the US, conduct initial clinical trials in the UK, and generate first revenues in the US market.
Investors
LeadEmpirical Ventures
Also participating
Oxford Innovation Finance
About OSSTEC
Stage
Series A
Headquarters
London, United Kingdom
Founded
2021
Team Size
6–20
Sectors
healthorthopaedicsmaterialsbiotechb2bdeep_hardware